The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Pathways to tamoxifen resistance
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Glaros, S., Atanaskova, N., Zhao, C., Skafar, D. F., & Reddy, K. B. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0285 · Cited by 41
RetractedCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Haagenson, C. (1971) · Cited by 1,773
Epithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
Concordance among Gene-Expression–Based Predictors for Breast Cancer
Fan, C., Oh, D. S., Wessels, L., Weigelt, B., Nuyten, D. S. A., Nobel, A. B., van't Veer, L. J., & Perou, C. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052933 · Cited by 1,341
The EGF receptor family as targets for cancer therapy
Mendelsohn, J., & Baselga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1204082 · Cited by 1,340
Shou, J., Massarweh, S., Osborne, C. K., Wakeling, A. E., Ali, S., Weiss, H., & Schiff, R. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh166 · Cited by 1,153
Living with or without cyclins and cyclin-dependent kinases
Sherr, C. J., & Roberts, J. M. (2004) · Genes & Development · doi:10.1101/gad.1256504 · Cited by 1,089
Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α
Campbell, R. A., Bhat-Nakshatri, P., Patel, N. M., Constantinidou, D., Ali, S., & Nakshatri, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010840200 · Cited by 968
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885
Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C., Hilsenbeck, S. G., Fuqua, S. A. W., Wong, J., Allred, D. C., Clark, G. M., & Schiff, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.353 · Cited by 786
Bardou, V.-J., Arpino, G., Elledge, R. M., Osborne, C. K., & Clark, G. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.099 · Cited by 752
mTOR, translation initiation and cancer
Mamane, Y., Petroulakis, E., LeBacquer, O., & Sonenberg, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209888 · Cited by 607
Clark, A. S., West, K. A., Streicher, S. A., & Dennis, P. A. (2002) · PubMed · Cited by 589
Knowlden, J. M., Hutcheson, I. R., Jones, H. E., Madden, T., Gee, J. M. W., Harper, M. E., Barrow, D., Wakeling, A. E., & Nicholson, R. I. (2003) · Endocrinology · doi:10.1210/en.2002-220620 · Cited by 521
Structure–function relationship of estrogen receptor α and β: Impact on human health
Ascenzi, P., Bocedi, A., & Marino, M. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.07.001 · Cited by 499
Gutierrez, M. C., Detre, S., Johnston, S., Mohsin, S. K., Shou, J., Allred, D. C., Schiff, R., Osborne, C. K., & Dowsett, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.172 · Cited by 489
Ottaviano, Y. L., Issa, J. J., Parl, F. F., Smith, H. S., Baylin, S. B., & Davidson, N. E. (1994) · PubMed · Cited by 481
Estrogen receptor phosphorylation
Lannigan, D. A. (2003) · Steroids · doi:10.1016/s0039-128x(02)00110-1 · Cited by 480
Chan, S., Scheulen, M. E., Johnston, S., Mross, K., Cardoso, F., Dittrich, C., Eiermann, W., Hess, D., Morant, R., Semiglazov, V., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.66.130 · Cited by 468
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
Osborne, C. K., Wakeling, A., & Nicholson, R. I. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601629 · Cited by 414
Estrogen Receptor Mutations in Human Disease
Herynk, M. H., & Fuqua, S. A. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0010 · Cited by 400
Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance
Clarke, R., Leonessa, F., Welch, J. N., & Skaar, T. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01479-0 · Cited by 397
Selective Estrogen Receptor Modulators
Frasor, J., Stossi, F., Danes, J. M., Komm, B., Lyttle, C. R., & Katzenellenbogen, B. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3326 · Cited by 395
deGraffenried, L. A., Friedrichs, W. E., Russell, D. H., Donzis, E. J., Middleton, A. K., Silva, J. M., Roth, R. A., & Hidalgo, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0035 · Cited by 387
Kurokawa, H., Lenferink, A. E. G., Simpson, J. F., Pisacane, P. I., Sliwkowski, M. X., Forbes, J. T., & Arteaga, C. L. (2000) · PubMed · Cited by 363
Ottenhoff-Kalff, A. E., Rijksen, G., van Beurden, E. A., Hennipman, A., Michels, A. A., & Staal, G. E. J. (1992) · PubMed · Cited by 348
Tamoxifen for Prevention of Breast Cancer
Cersosimo, R. J. (2003) · Annals of Pharmacotherapy · doi:10.1177/106002800303700219 · Cited by 343
Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling
Jansen, M. P. H. M., Foekens, J. A., van Staveren, I. L., Dirkzwager-Kiel, M. M., Ritstier, K., Look, M. P., Meijer-van Gelder, M. E., Sieuwerts, A. M., Portengen, H., Dorssers, L. C. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.145 · Cited by 340
Boulay, A., Rudloff, J., Ye, J., Zumstein-Mecker, S., O'Reilly, T., Evans, D. B., Chen, S., & Lane, H. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2402 · Cited by 335
Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells
Doisneau-Sixou, S. F., Sergio, C. M., Carroll, J. S., Hui, R., Musgrove, E. A., & Sutherland, R. L. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100179 · Cited by 333
p130Cas: a versatile scaffold in signaling networks
Defilippi, P., Di Stefano, P., & Cabodi, S. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.03.003 · Cited by 326
Chang, E. C., Frasor, J., Komm, B., & Katzenellenbogen, B. S. (2006) · Endocrinology · doi:10.1210/en.2006-0563 · Cited by 325
Johnston, S. R. D., Saccani‐Jotti, G., Smith, I. E., Salter, J., Newby, J. C., Coppen, M. J., Ebbs, S. R., & Dowsett, M. (1995) · PubMed · Cited by 301
Akt Signaling and Cancer: Surviving but not Moving On
Toker, A., & Yoeli-Lerner, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0743 · Cited by 295
Coregulators in Nuclear Estrogen Receptor Action: From Concept to Therapeutic Targeting
Hall, J. M. (2005) · Molecular Interventions · doi:10.1124/mi.5.6.7 · Cited by 295
Zhang, Q., Borg, Å., Wolf, D. M., Oesterreich, S., & Fuqua, S. A. W. (1997) · PubMed · Cited by 291
Chen, D., Riedl, T., Washbrook, E., Pace, P. E., Coombes, R. C., Egly, J.-M., & Ali, S. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00004-3 · Cited by 290
Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance
Lewis, J. S., & Jordan, V. C. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.02.028 · Cited by 281
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.
Fuqua, S. A. W., Wiltschke, C., ZHANG, Q. X., Borg, Å., Castles, C. G., Friedrichs, W. E., Hopp, T., Hilsenbeck, S. G., Mohsin, S. K., O'Connell, P., et al. (2000) · PubMed · Cited by 278
Hiscox, S., Morgan, L., Green, T. P., Barrow, D., Gee, J., & Nicholson, R. I. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9120-9 · Cited by 274
VERBEEK, B. S., VROOM, T. M., ADRIAANSEN-SLOT, S. S., OTTENHOFF-KALFF, A. E., GEERTZEMA, J. G. N., HENNIPMAN, A., & RIJKSEN, G. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199612)180:4<383::aid-path686>3.0.co;2-n · Cited by 270
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
Kirkegaard, T., Witton, C. J., McGlynn, L. M., Tovey, S. M., Dunne, B., Lyon, A., & Bartlett, J. M. (2005) · The Journal of Pathology · doi:10.1002/path.1829 · Cited by 268
Roodi, N., Bailey, L. R., Kao, W.-Y., Verrier, C. S., Yee, C. J., Dupont, W. D., & Parl, F. F. (1995) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/87.6.446 · Cited by 266
Michalides, R., Griekspoor, A., Balkenende, A., Verwoerd, D., Janssen, L., Jalink, K., Floore, A., Velds, A., van `t Veer, L., & Neefjes, J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.016 · Cited by 260
Phosphorylation of Human Estrogen Receptor α by Protein Kinase A Regulates Dimerization
Chen, D., Pace, P. E., Coombes, R. C., & Ali, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1002 · Cited by 260
McClelland, R. A., Barrow, D., Madden, T., Dutkowski, C. M., Pamment, J., Knowlden, J. M., Gee, J. M. W., & Nicholson, R. I. (2001) · Endocrinology · doi:10.1210/en.142.7.2776 · Cited by 258
Sutherland, R. L., & Musgrove, E. A. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000023591.45568.77 · Cited by 258
Arpino, G., Green, S. J., Allred, D. C., Lew, D., Martino, S., Osborne, C. K., & Elledge, R. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0110 · Cited by 255
Involvement of estrogen receptor β in terminal differentiation of mammary gland epithelium
Förster, C., Mäkela, S., Wärri, A., Kietz, S., Becker, D., Hultenby, K., Warner, M., & Gustafsson, J.-Å. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192561299 · Cited by 250
Helguero, L. A., Faulds, M. H., Gustafsson, J.-Å., & Haldosén, L.-A. (2005) · Oncogene · doi:10.1038/sj.onc.1208807 · Cited by 250
Fan, M., Yan, P. S., Hartman-Frey, C., Chen, L., Paik, H., Oyer, S. L., Salisbury, J. D., Cheng, A. S. L., Li, L., Abbosh, P. H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1666 · Cited by 248
Butt, A. J., McNeil, C. M., Musgrove, E. A., & Sutherland, R. L. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00993 · Cited by 244
Cell cycle control in breast cancer cells
Caldon, C. E., Daly, R. J., Sutherland, R. L., & Musgrove, E. A. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20690 · Cited by 238
Chen, D., Washbrook, E., Sarwar, N., Bates, G. J., Pace, P. E., Thirunuvakkarasu, V., Taylor, J., Epstein, R. J., Fuller-Pace, F. V., Egly, J.-M., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205420 · Cited by 236
Weis, K. E. (1996) · Molecular Endocrinology · doi:10.1210/me.10.11.1388 · Cited by 236
Cariou, S., Donovan, J. C. H., Flanagan, W. M., Milic, A., Bhattacharya, N., & Slingerland, J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160016897 · Cited by 224
Stossi, F., Barnett, D. H., Frasor, J., Komm, B., Lyttle, C. R., & Katzenellenbogen, B. S. (2004) · Endocrinology · doi:10.1210/en.2003-1682 · Cited by 219
Kenny, F. S., Hui, R., Musgrove, E. A., Gee, J. M. W., Blamey, R. W., Nicholson, R. I., Sutherland, R. L., & Robertson, J. F. R. (1999) · PubMed · Cited by 214
Gee, J. M., Robertson, J. F., Gutteridge, E., Ellis, I. O., Pinder, S. E., Rubini, M., & Nicholson, R. I. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01005 · Cited by 209
Escande, A., Pillon, A., Servant, N., Cravedi, J.-P., Larrea, F., Muhn, P., Nicolas, J.-C., Cavaillès, V., & Balaguer, P. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.002 · Cited by 208
Sharma, D., Saxena, N. K., Davidson, N. E., & Vertino, P. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0402 · Cited by 208
Functions of the adapter protein Cas: signal convergence and the determination of cellular responses
Bouton, A. H., Riggins, R. B., & Bruce-Staskal, P. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204785 · Cited by 206
Self-citationRogatsky, I., Trowbridge, J. M., & Garabedian, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22296 · Cited by 205
Estrogens and cell-cycle regulation in breast cancer
Foster, J. S., Henley, D. C., Ahamed, S., & Wimalasena, J. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00436-2 · Cited by 203
Ellis, M. J., Coop, A., Singh, B., Yu, T., Llombart‐Cussac, A., Jänicke, F., Mauriac, L., Quebe‐Fehling, E., Chaudri‐Ross, H. A., Evans, D. B., et al. (2003) · PubMed · Cited by 202
Joel, P. B., Traish, A. M., & Lannigan, D. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13317 · Cited by 202
Lee, H., & Bai, W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5835-5845.2002 · Cited by 202
Activation of PI3K/Akt signaling and hormone resistance in breast cancer
Tokunaga, E., Kimura, Y., Mashino, K., Oki, E., Kataoka, A., Ohno, S., Morita, M., Kakeji, Y., Baba, H., & Maehara, Y. (2006) · Breast Cancer · doi:10.2325/jbcs.13.137 · Cited by 199
Brünner, N., Boysen, B., JIRUS, S., Skaar, T. C., Holst‐Hansen, C., Lippman, J., Frandsen, T. L., Spang‐Thomsen, M., Fuqua, S. A. W., & Clarke, R. C. (1997) · PubMed · Cited by 196
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen
Encarnaci�n, C. A., Ciocca, D. R., McGuire, W. L., Clark, G. M., Fuqua, S. A. W., & Osborne, C. K. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00665801 · Cited by 194
Park, K.-J., Krishnan, V., O’Malley, B. W., Yamamoto, Y., & Gaynor, R. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.006 · Cited by 193
Estrogen receptor mutations in tamoxifen-resistant breast cancer.
Karnik, P. S., Kulkarni, S., Liu, X.-P., Budd, G. T., & Bukowski, R. M. (1994) · PubMed · Cited by 192
Arnold, S. F. (1995) · Molecular Endocrinology · doi:10.1210/me.9.1.24 · Cited by 190
Knowlden, J. M., Hutcheson, I. R., Barrow, D., Gee, J. M. W., & Nicholson, R. I. (2005) · Endocrinology · doi:10.1210/en.2005-0247 · Cited by 188
Src family kinases and HER2 interactions in human breast cancer cell growth and survival
Belsches-Jablonski, A. P., Biscardi, J. S., Peavy, D. R., Tice, D. A., Romney, D. A., & Parsons, S. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204205 · Cited by 185
Wang, R.-A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf543 · Cited by 183
Epigenetic Information and Estrogen Receptor Alpha Expression in Breast Cancer
Giacinti, L., Claudio, P. P., Lopez, M., & Giordano, A. (2006) · The Oncologist · doi:10.1634/theoncologist.11-1-1 · Cited by 183
Akt: Versatile Mediator of Cell Survival and Beyond
Kim, D.-H., & Chung, J.-K. (2002) · BMB Reports · doi:10.5483/bmbrep.2002.35.1.106 · Cited by 182
Matthews, J., Wihlén, B., Tujague, M., Wan, J., Ström, A., & Gustafsson, J.-Å. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0140 · Cited by 179
Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor
Arnold, S. F. (1994) · Molecular Endocrinology · doi:10.1210/me.8.9.1208 · Cited by 176
Navolanic, P., Steelman, L., & McCubrey, J. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.2.237 · Cited by 176
Garcia, M., Derocq, D., Freiss, G., & Rochefort, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11538 · Cited by 175
Schraml, P., Schwerdtfeger, G., Burkhalter, F., Raggi, A., Schmidt, D., Ruffalo, T., King, W., Wilber, K., Mihatsch, M. J., & Moch, H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63458-x · Cited by 175
Gee, J. M. W., Harper, M. E., Hutcheson, I. R., Madden, T. A., Barrow, D., Knowlden, J. M., McClelland, R. A., Jordan, N., Wakeling, A. E., & Nicholson, R. I. (2003) · Endocrinology · doi:10.1210/en.2003-0705 · Cited by 170
Goetz, M. P., Suman, V. J., Ingle, J. N., Nibbe, A. M., Visscher, D. W., Reynolds, C. A., Lingle, W. L., Erlander, M., Ma, X.-J., Sgroi, D. C., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1263 · Cited by 170
Oestrogen Receptor-Mediated Modulation of the EGFR/MAPK Pathway in Tamoxifen-Resistant MCF-7 Cells
Hutcheson, I. R., Knowlden, J. M., Madden, T.-A., Barrow, D., Gee, J. M. W., Wakeling, A. E., & Nicholson, R. I. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1025484908380 · Cited by 169
Stendahl, M., Kronblad, Å., Rydén, L., Emdin, S., Bengtsson, N. O., & Landberg, G. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601831 · Cited by 169
Likhite, V. S., Stossi, F., Kim, K., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0068 · Cited by 167
Biscardi, J. S., Belsches, A. P., & Parsons, S. J. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199804)21:4<261::aid-mc5>3.0.co;2-n · Cited by 165
Medunjanin, S., Hermani, A., Servi, B. D., Grisouard, J., Rincke, G., & Mayer, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506758200 · Cited by 162
Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens.
Thiantanawat, A., Long, B. J., & Brodie, A. M. H. (2003) · PubMed · Cited by 161
Kurokawa, H., & Arteaga, C. L. (2003) · PubMed · Cited by 159
Carroll, J. S., Prall, O. W. J., Musgrove, E. A., & Sutherland, R. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004424200 · Cited by 158
Schiff, R., Massarweh, S. A., Shou, J., Bharwani, L. D., Arpino, G., Rimawi, M. F., & Osborne, C. K. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0108-2 · Cited by 153
Akli, S., Zheng, P., Multani, A. S., Wingate, H. F., Pathak, S., Zhang, N., Tucker, S. L., Chang, S. S., & Keyomarsi, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3672 · Cited by 152
Distinct expression patterns of ER and ER in normal human mammary gland
Speirs, V., Skliris, G. P., Burdall, S. E., & Carder, P. J. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.5.371 · Cited by 152
Britton, D. J., Hutcheson, I. R., Knowlden, J. M., Barrow, D., Giles, M. G., McClelland, R. A., Gee, J. M. W., & Nicholson, R. I. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9070-2 · Cited by 151
Steroid Receptors and Cell Cycle in Normal Mammary Epithelium
Anderson, E., & Clarke, R. B. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000023584.01750.16 · Cited by 149
Brinkman, A., van der Flier, S., Kok, E. M., & Dorssers, L. C. J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.112 · Cited by 146
Regulation of c-SRC Activity and Function by the Adapter Protein CAS
Burnham, M. R., Bruce-Staskal, P. J., Harte, M. T., Weidow, C. L., Ma, A., Weed, S. A., & Bouton, A. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5865-5878.2000 · Cited by 145
Self-citationKumar, R., Mandal, M., Lipton, A., Harvey, H. A., & Thompson, C. B. (1996) · PubMed · Cited by 144
Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen
Shoman, N. M., Klassen, S., McFadden, A., Bickis, M., Torlakovic, E., & Chibbar, R. (2004) · Modern Pathology · doi:10.1038/modpathol.3800296 · Cited by 142
Perey, L., Paridaens, R., Hawle, H., Zaman, K., Nolè, F., Wildiers, H., Fiche, M., Dietrich, D., Clément, P., Köberle, D., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl341 · Cited by 142
Donovan, J. C. H., Milic, A., & Slingerland, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106448200 · Cited by 137
Molecular and pharmacological aspects of antiestrogen resistance
Clarke, R. C., Skaar, T. C., Bouker, K. B., Davis, N., Lee, Y. R., Welch, J. N., & Leonessa, F. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00193-x · Cited by 135
IFN-γ and TNF Regulate Macrophage Expression of the Chemotactic S100 Protein S100A8
Xu, K., & Geczy, C. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4916 · Cited by 132
Cabodi, S., Moro, L., Baj, G., Smeriglio, M., Stefano, P. D., Gippone, S., Surico, N., Silengo, L., Turco, E., Tarone, G., et al. (2004) · Journal of Cell Science · doi:10.1242/jcs.01025 · Cited by 128
Increased Constitutive Activity of PKB/Akt in Tamoxifen Resistant Breast Cancer MCF-7 Cells
Jordan, N., Gee, J. M. W., Barrow, D., Wakeling, A. E., & Nicholson, R. I. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000041623.21338.47 · Cited by 127
Santen, R. J., Song, R., Zhang, Z., Kumar, R., Jeng, M. H., Masamura, A., Lawrence, J., Berstein, L. M., & Yue, W. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01018 · Cited by 125
Graham, M. L., Krett, N. L., Miller, L. A., Leslie, K. K., Gordon, D. F., Wood, W. M., Wei, L. L., & Horwitz, K. B. (1990) · PubMed · Cited by 122
van Agthoven, T., van Agthoven, T. L. A., Dekker, A., van der Spek, P. J., Vreede, L., & Dorssers, L. C. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2799 · Cited by 122
Hiscox, S., Morgan, L. D., Barrow, D., Dutkowski, C. M., Wakeling, A. E., & Nicholson, R. I. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000037697.76011.1d · Cited by 121
Mukherjee, S., & Conrad, S. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502278200 · Cited by 120
Bcar1/p130Cas Protein and Primary Breast Cancer: Prognosis and Response to Tamoxifen Treatment
van der Flier, S., Brinkman, A., Look, M. P., Kok, E. M., Gelder, M. E. M., Klijn, J. G. M., Dorssers, L. C. J., & Foekens, J. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.120 · Cited by 119
Pure oestrogen antagonists for the treatment of advanced breast cancer
Howell, A. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.00846 · Cited by 118
Nonendocrine Pathways and Endocrine Resistance
Nicholson, R. I., Hutcheson, I. R., Knowlden, J. M., Jones, H., Harper, M. E., Jordan, N., Hiscox, S., Barrow, D., & Gee, J. M. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-031206 · Cited by 117
Limits of Predictive Models Using Microarray Data for Breast Cancer Clinical Treatment Outcome
Reid, J. F., Lusa, L., Cecco, L. D., Coradini, D., Veneroni, S., Daidone, M. G., Gariboldi, M., & Pierotti, M. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji153 · Cited by 116
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
Michalides, R. J. A. M., van Tinteren, H., Balkenende, A., Vermorken, J. B., Benraadt, J., Huldij, J. C., & van Diest, P. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600072 · Cited by 115
Yamashita, H., Nishio, M., Kobayashi, S., Ando, Y., Sugiura, H., Zhang, Z., Hamaguchi, M., Mita, K., Fujii, Y., & Iwase, H. (2005) · Breast Cancer Research · doi:10.1186/bcr1285 · Cited by 111
Hui, R., Finney, G. L., Carroll, J. S., Lee, C. S. L., Musgrove, E. A., & Sutherland, R. L. (2002) · PubMed · Cited by 109
Yarden, R. I., Wilson, M. A., & Chrysogelos, S. A. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1142 · Cited by 106
Sarwar, N., Kim, J. S., Jiang, J., Peston, D., Sinnett, H. D., Madden, P. B., Gee, J. M. W., Nicholson, R. I., Lykkesfeldt, A. E., Shousha, S., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01123 · Cited by 105
Johnston, S. R. D. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2125 · Cited by 104
Zou, A., Marschke, K. B., Arnold, K. E., Berger, E. M., Fitzgerald, P., Mais, D. E., & Allegretto, E. A. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.3.0253 · Cited by 103
Gotoh, T., Cai, D. D., Tian, X., Feig, L. A., & Lerner, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003074200 · Cited by 100
Yang, Z., Barnes, C. J., & Kumar, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0740-3 · Cited by 99
Antiestrogens, Aromatase Inhibitors, and Apoptosis in Breast Cancer
Riggins, R. B., Bouton, A. H., Liu, M., & Clarke, R. C. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)71007-4 · Cited by 97
Self-citationRiggins, R. B., Thomas, K. S., Ta, H. Q., Wen, J., Davis, R. J., Schuh, N. R., Donelan, S. S., Owen, K. A., Gibson, M. A., Shupnik, M. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3952 · Cited by 97
Self-citationAntiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth
Frogne, T., Jepsen, J. S., Larsen, S. S., Fog, C. K., Brockdorff, B. L., & Lykkesfeldt, A. E. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00946 · Cited by 95
New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists
Carraway, H. E., & Hidalgo, M. M. (2004) · Breast Cancer Research · doi:10.1186/bcr927 · Cited by 94
Kurokawa, H., & Arteaga, C. L. (2001) · PubMed · Cited by 94
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels
Fernö, M., Stål, O., Baldetrop, B., Hatschek, T., Källström, A.-C., Malmström, P., Nordenskjöld, B. A., & Rydén, S. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006332423620 · Cited by 94
Robanus-Maandag, E. C., Bosch, C. A. J., Kristel, P., Hart, A. A. M., Faneyte, I. F., Nederlof, P. M., Peterse, J. L., & van de Vijver, M. J. (2003) · The Journal of Pathology · doi:10.1002/path.1385 · Cited by 93
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer
Span, P. N., Tjan‐Heijnen, V. C. G., Manders, P., Beex, L. V. A. M., & Sweep, F. C. G. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206818 · Cited by 93
A Novel 80 kDa Human Estrogen Receptor Containing a Duplication of Exons 6 and 7
Pink, J. J., Wu, S.-W., Wolf, D. M., et al. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.5.962 · Cited by 86
Synergistic Promotion of c-Src Activation and Cell Migration by Cas and AND-34/BCAR3
Riggins, R. B., Quilliam, L. A., & Bouton, A. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303535200 · Cited by 85
Self-citationBiological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance
Dowsett, M., Nicholson, R. I., & Pietras, R. J. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9037-3 · Cited by 81
Hur, J., Chesnes, J., Coser, K. R., Lee, R. S., Geck, P., Isselbacher, K. J., & Shioda, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307337101 · Cited by 81
Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity
deGraffenried, L. A., Friedrichs, W. E., Fulcher, L. C., Fernandes, G., Silva-Fisher, J., Peralba, J.-M., & Hidalgo, M. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg291 · Cited by 81
Weitsman, G. E., Li, L., Skliris, G. P., Davie, J., Ung, K., Niu, Y., Curtis-Snell, L., Tomes, L., Watson, P. H., & Murphy, L. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4111 · Cited by 80
Letrozole-, Anastrozole-, and Tamoxifen-Responsive Genes in MCF-7aro Cells: A Microarray Approach
Itoh, T., Karlsberg, K., Kijima, I., Yuan, Y., Smith, D. D., Ye, J., & Chen, S. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0122 · Cited by 80
Murphy, L. C., Niu, Y., Snell, L., & Watson, P. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0191 · Cited by 78
Becker, M., Sommer, A., Krätzschmar, J., Seidel, H., Pohlenz, H., & Fichtner, I. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.151.4.1 · Cited by 78
Tremblay, G. B., Tremblay, A., Labrie, F., & Giguère, V. (1998) · PubMed · Cited by 77
Balasenthil, S., Barnes, C. J., Rayala, S. K., & Kumar, R. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.071 · Cited by 75
Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?
Murphy, L. C., & Watson, P. H. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01141 · Cited by 74
Dorssers, L. C. J., van Agthoven, T., Dekker, A., van Agthoven, T. L., & Kok, E. M. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.7.8413311 · Cited by 71
Bouker, K. B., Skaar, T. C., Fernández, D., O’Brien, K. A., Riggins, R. B., Cao, D., & Clarke, R. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3602 · Cited by 70
Self-citationCyclin D1 Is Necessary for Tamoxifen-Induced Cell Cycle Progression in Human Breast Cancer Cells
Kilker, R. L., & Planas-Silva, M. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1755 · Cited by 68
Kuske, B., Naughton, C., Moore, K. M., MacLeod, K. G., Miller, W. R., Clarke, R. C., Langdon, S. P., & Cameron, D. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01257 · Cited by 68
Function of Estrogen Receptor Tyrosine 537 in Hormone Binding, DNA Binding, and Transactivation
Yudt, M. R., Vorojeikina, D. P., Zhong, L., Skafar, D. F., Sasson, S., Gasiewicz, T. A., & Notides, A. C. (1999) · Biochemistry · doi:10.1021/bi9911132 · Cited by 65
Holloway, J. N., Murthy, S., & El‐Ashry, D. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0048 · Cited by 65
Pérez‐Tenorio, G., Berglund, F., Merca, A. E., Nordenskjöld, B. A., Rutqvist, L. E., Skoog, L. K., & Stål, O. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1031 · Cited by 65
What do we know about the mechanisms of aromatase inhibitor resistance?
Chen, S., Masri, S., Wang, X., Phung, S., Yuan, Y.-C., & Wu, X. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.012 · Cited by 64
Felekkis, K. N., Narsimhan, R. P., Near, R. I., Castro, A. F., Zheng, Y., Quilliam, L. A., & Lerner, A. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.32.3.1 · Cited by 64
The molecular determinants of estrogen receptor pharmacology
McDonnell, D. P. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.03.006 · Cited by 63
Non-Steroidal Subtype Selective Estrogens
Veeneman, G. H. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764662 · Cited by 62
Involvement of R-Ras and Ral GTPases in estrogen-independent proliferation of breast cancer cells
Yu, Y., & Feig, L. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205961 · Cited by 62
Role of estrogen receptor α transcriptional coregulators in tamoxifen resistance in breast cancer
Girault, I., Bièche, I., & Lidereau, R. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.06.003 · Cited by 60
Kilker, R. L., Hartl, M. W., Rutherford, T. M., & Planas-Silva, M. D. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.05.005 · Cited by 59
Genomics-Based Prognosis and Therapeutic Prediction in Breast Cancer
Jeffrey, S. S., Lønning, P. E., & Hillner, B. E. (2005) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2005.0016 · Cited by 58
Update on the use of aromatase inhibitors in breast cancer
Brueggemeier, R. W. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.14.1919 · Cited by 58
Nicholson, R. I., Hutcheson, I. R., Britton, D., Knowlden, J. M., Jones, H., Harper, M. E., Hiscox, S., Barrow, D., & Gee, J. M. W. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.006 · Cited by 58
The GDP Exchange Factor AND-34 Is Expressed in B Cells, Associates With HEF1, and Activates Cdc42
Cai, D. D., Felekkis, K. N., Near, R. I., O’Neill, G. M., van Seventer, J. M., Golemis, E. A., & Lerner, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.969 · Cited by 56
Bowie, M. L., Dietze, E. C., Delrow, J. J., Bean, G. R., Troch, M. M., Marjoram, R. J., & Seewaldt, V. L. (2004) · Oncogene · doi:10.1038/sj.onc.1208120 · Cited by 55
Fulvestrant (‘Faslodex’): Current and future role in breast cancer management
Howell, A. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.08.001 · Cited by 54
Cowell, L., Graham, J. D., Bouton, A. H., Clarke, C. L., & O’Neill, G. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209747 · Cited by 53
Self-citationPohl, G., Rudas, M., Dietze, O., Lax, S., Markis, E., Pirker, R., Zielinski, C. C., Hausmaninger, H., Kubista, E., Samonigg, H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.021 · Cited by 53
CHEN, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00014-9 · Cited by 52
(1992) · PubMed · Cited by 50
Dhillon, N. K., & Mudryj, M. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205576 · Cited by 50
Bad expression predicts outcome in patients treated with tamoxifen
Cannings, E., Kirkegaard, T., Tovey, S., Dunne, B., Cooke, T. G., & Bartlett, J. M. S. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9323-8 · Cited by 49
Brodie, A. M., Sabnis, G. J., & Jelovac, D. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.002 · Cited by 47
Desmedt, C., Ouriaghli, F. E., Durbecq, V., Soree, A., Colozza, M., de Azambuja, E., Paesmans, M., Larsimont, D., Buyse, M. E., Harris, A. L., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22149 · Cited by 46
Doisneau-Sixou, S. F., Cestac, P., Faye, J., Favre, G., & Sutherland, R. L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11263 · Cited by 46
Carroll, J. S., Lynch, D. K., Swarbrick, A., Renoir, J., Šarčević, B., Daly, R. J., Musgrove, E. A., & Sutherland, R. L. (2003) · PubMed · Cited by 44
van den Berg, H., Lynch, M., Martin, J., Nelson, J., Dickson, G., & Crockard, A. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.107 · Cited by 44
Cesarone, G., Garofalo, C., Abrams, M. T., Igoucheva, O., Alexeev, V. Y., Yoon, K., Surmacz, E., & Wickstrom, E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20817 · Cited by 43
Murphy, L. C., Weitsman, G. E., Skliris, G. P., Teh, E., Li, L., Peng, B., Davie, J., Ung, K., Niu, Y., Troup, S., et al. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.021 · Cited by 41
Sommer, A., Hoffmann, J., Lichtner, R. B., Schneider, M. R., & Parczyk, K. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00139-0 · Cited by 40
The Clinical Relevance of Steroid Hormone Receptor Corepressors
Kumar, R., Gururaj, A. E., Vadlamudi, R. K., & Rayala, S. K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1276 · Cited by 40
AKT Regulation of Estrogen Receptor β Transcriptional Activity in Breast Cancer
Duong, B. N., Elliott, S. G., Frigo, D. E., Melnik, L. I., Vanhoy, L., Tomchuck, S. L., LeBeau, H., David, O., Beckman, B. S., Alam, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3845 · Cited by 34
Planas-Silva, M. D., & Hamilton, K. N. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0398-z · Cited by 26
TAS-108: A Novel Steroidal Antiestrogen
Buzdar, A. U. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.906s.11.2 · Cited by 17
Characterization of AND‐34 Function and Signaling
Felekkis, K. N., Quilliam, L. A., & Lerner, A. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07006-0 · Cited by 11
Cariou, S. (2000) · Medical Entomology and Zoology · Cited by 6
Cited by
Biological determinants of endocrine resistance in breast cancer
Musgrove, E. A., & Sutherland, R. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2713 · Cited by 1,252
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Robinson, D. R., Wu, Y.-M., Vats, P., Su, F., Lonigro, R. J., Cao, X., Kalyana-Sundaram, S., Wang, R., Ning, Y., Hodges, L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2823 · Cited by 1,145
Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
Muranen, T., Selfors, L. M., Worster, D. T., Iwanicki, M. P., Song, L., Morales, F. C., Gao, S., Mills, G. B., & Brugge, J. S. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.024 · Cited by 384
Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
Pandey, D. P., Lappano, R., Albanito, L., Madeo, A., Maggiolini, M., & Picard, D. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.304 · Cited by 327
Thangavel, C., Dean, J. L., Ertel, A., Knudsen, K. E., Aldaz, C. M., Witkiewicz, A. K., Clarke, R., & Knudsen, E. S. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0262 · Cited by 302
Metadata
- Authors
- Riggins, R. B., Schrecengost, R. S., Guerrero, M. S., & Bouton, A. H.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 256
- Issue
- 1
- Pages
- 1-24
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2089595068
- Cited by
- 277
- References
- 192
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.